Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom W J Huizinga

Showing results (51-60 of 519) with videos related to

Pageof 52
Sort By:
European Journal of Immunology|February 11, 2016
Human mast cells costimulate T cells through a CD28-independent interactionJolien Suurmond, Annemarie L Dorjée, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|September 11, 2014
Belimumab after rituximab as maintenance therapy in lupus nephritisTineke Kraaij, Tom W J Huizinga, Ton J Rabelink, et al.
Nature Reviews. Rheumatology|February 2, 2012
The influence of ACPA status and characteristics on the course of RAAnnemiek Willemze, Leendert A Trouw, René E M Toes, et al.
Annals of the Rheumatic Diseases|September 11, 2010
Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic reviewErlangga Yusuf, Marion C Kortekaas, Iain Watt, et al.
Current Opinion in Pharmacology|April 13, 2013
Personalized medicine: predicting responses to therapy in patients with RAMarianne van den Broek, Karen Visser, Cornelia F Allaart, et al.
Modern Rheumatology|July 7, 2011
Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritisParawee Suwannalai, Leendert A Trouw, Rene E M Toes, et al.
Current Rheumatology Reports|September 16, 2006
Genetic markers of treatment response in rheumatoid arthritisJoanna Wesoly, Judith A M Wessels, Henk-Jan Guchelaar, et al.
Human Immunology|May 27, 2006
HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMARené R P de Vries, Tom W J Huizinga, René E M Toes
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritisFloris van Gaalen, Andreea Ioan-Facsinay, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|December 15, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
Pageof 52

Showing results (51-60 of 519) with videos related to

Sort By:
Pageof 52
European Journal of Immunology|February 11, 2016
Human mast cells costimulate T cells through a CD28-independent interactionJolien Suurmond, Annemarie L Dorjée, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|September 11, 2014
Belimumab after rituximab as maintenance therapy in lupus nephritisTineke Kraaij, Tom W J Huizinga, Ton J Rabelink, et al.
Nature Reviews. Rheumatology|February 2, 2012
The influence of ACPA status and characteristics on the course of RAAnnemiek Willemze, Leendert A Trouw, René E M Toes, et al.
Annals of the Rheumatic Diseases|September 11, 2010
Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic reviewErlangga Yusuf, Marion C Kortekaas, Iain Watt, et al.
Current Opinion in Pharmacology|April 13, 2013
Personalized medicine: predicting responses to therapy in patients with RAMarianne van den Broek, Karen Visser, Cornelia F Allaart, et al.
Modern Rheumatology|July 7, 2011
Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritisParawee Suwannalai, Leendert A Trouw, Rene E M Toes, et al.
Current Rheumatology Reports|September 16, 2006
Genetic markers of treatment response in rheumatoid arthritisJoanna Wesoly, Judith A M Wessels, Henk-Jan Guchelaar, et al.
Human Immunology|May 27, 2006
HLA and RA revisited: citrullinated food for the SE hypothesis, the DR6 effect, and NIMARené R P de Vries, Tom W J Huizinga, René E M Toes
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritisFloris van Gaalen, Andreea Ioan-Facsinay, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|December 15, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
Pageof 52